Spiriva HandiHaler Boehringer Ingelheim - Treatment for Chronic Obstructive Pulmonary Disease (COPD)
Spiriva is an inhaled anticholinergic medication for the long-term, once-daily maintenance treatment of bronchospasm associated with Chronic Obstructive Pulmonary Disease (COPD).Posted: January 2004
Related Articles:
- FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations - December 18, 2009
